ORSALIA PALAPANIS: Open Payments
NPI 1861254690 · LINWOOD, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$275 in 10 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $168 · 2025 $275
Food & beverage: $275
| Company | Payments | Amount |
|---|---|---|
| ViiV Healthcare Company | 1 | $124 |
| Lilly USA, LLC | 3 | $48 |
| Teva Pharmaceuticals USA, Inc. | 2 | $32 |
| ABBVIE INC. | 2 | $29 |
| Insulet Corporation | 1 | $23 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $20 |
Products named: RUKOBIA, MOUNJARO, AUSTEDO XR, VRAYLAR, Omnipod, XIFAXAN.
Industry payments across NJ — which companies pay providers there.
